Corrigendum to “Spironolactone inhibits endothelial-mesenchymal transition via the adenosine A2A receptor to reduce cardiorenal fibrosis in rats” [Life Sci. 224 (2019) 177–186]
-
Published:2022-06
Issue:
Volume:298
Page:120430
-
ISSN:0024-3205
-
Container-title:Life Sciences
-
language:en
-
Short-container-title:Life Sciences
Author:
Chen Xingxing,Ge Wenhua,Dong Tiancheng,Hu Jie,Chen Lingzhi,Fan Xiaofang,Gong Yongsheng,Zhou Hao
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine